ScholarWorks@Dongguk University

Browsing by Lee, Seok-YongAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 20 of 25

SCIESCOPUSKCI
ABCB1 c.2677G>T/c.3435C>T diplotype increases the early-phase oral absorption of losartan

Shin, Hyo-Bin; Jung, Eui Hyun; Kang, Pureum; Lim, Chang Woo; Oh, Kyung-Yul; Cho, Chang-Keun; Lee, Yun Jeong; Choi, Chang-Ik; Jang, Choon-Gon; Lee, Seok-Yong, et al.

ArticleIssue Date2020CitationARCHIVES OF PHARMACAL RESEARCH, v.43, no.11, pp 1187 - 1196PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes

Byeon, Ji-Young; Kim, Young-Hoon; Lee, Choong-Min; Kim, Se-Hyung; Chae, Won-Ki; Jung, Eui-Hyun; Choi, Chang-Ik; Jang, Choon-Gon; Lee, Seok-Yong; Bae, Jung-Woo, et al.

ArticleIssue Date2018CitationARCHIVES OF PHARMACAL RESEARCH, v.41, no.9, pp 921 - 930PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites

Kim, Mi-Jung; Byeon, Ji-Yeong; Kim, Young-Hoon; Kim, Se-Hyung; Lee, Choong-Min; Jung, Eui Hyun; Chae, Won Ki; Lee, Yun Jeong; Jang, Choon-Gon; Lee, Seok-Yong, et al.

ArticleIssue Date2018CitationARCHIVES OF PHARMACAL RESEARCH, v.41, no.3, pp 347 - 353PublisherPHARMACEUTICAL SOC KOREA
SCISCIESCOPUS
Effects of CYP2C19 and CYP3A5 genetic polymorphisms on the pharmacokinetics of cilostazol and its active metabolites

Lee, Hye-In; Byeon, Ji-Young; Kim, Young-Hoon; Lee, Choong-Min; Choi, Chang-Ik; Jang, Choon-Gon; Bae, Jung-Woo; Lee, Yun Jeong; Lee, Seok-Yong

ArticleIssue Date2018CitationEUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, v.74, no.11, pp 1417 - 1426PublisherSPRINGER HEIDELBERG
SCIESCOPUSKCI
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjectsopen access

Kang, Pureum; Cho, Chang-Keun; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Choi, Chang-Ik; Bae, Jung-Woo

ArticleIssue Date2023CitationArchives of Pharmacal Research, v.46, no.5, pp 438 - 447Publisher대한약학회
SCIESCOPUSKCI
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite

Kim, Se-Hyung; Kim, Do-Hoon; Byeon, Ji-Yeong; Kim, Young-Hoon; Kim, Dong-Hyun; Lim, Hye-Jin; Lee, Choong-Min; Whang, Sang Sup; Choi, Chang-Ik; Bae, Jung-Woo, et al.

ArticleIssue Date2017CitationARCHIVES OF PHARMACAL RESEARCH, v.40, no.3, pp 382 - 390PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast

Lee, Hyun-Jee; Kim, Young-Hoon; Kim, Se-Hyung; Lee, Choong-Min; Yang, Ae-Yun; Jang, Choon-Gon; Lee, Seok-Yong; Bae, Jung-Woo; Choi, Chang-Ik

ArticleIssue Date2016CitationARCHIVES OF PHARMACAL RESEARCH, v.39, no.7, pp 1013 - 1019PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects

Lee, Yun-Jeong; Byeon, Ji-Yeong; Kim, Young-Hoon; Kim, Se-Hyung; Choi, Chang-Ik; Bae, Jung-Woo; Sohn, Uy-Dong; Jang, Choon-Gon; Lee, Jeongmi; Lee, Seok-Yong

ArticleIssue Date2015CitationARCHIVES OF PHARMACAL RESEARCH, v.38, no.6, pp 1232 - 1237PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide

Bae, Jung-Woo; Oh, Kyung-Yul; Yoon, So-Jung; Shin, Hyo-Bin; Jung, Eui Hyun; Cho, Chang-Keun; Lim, Chang Woo; Kang, Pureum; Choi, Chang-Ik; Jang, Choon-Gon, et al.

ArticleIssue Date2020CitationARCHIVES OF PHARMACAL RESEARCH, v.43, no.11, pp 1207 - 1213PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisoneopen access

Cho, Chang-Keun; Byeon, Ji-Young; Kang, Pureum; Park, Jung-In; Jang, Choon-Gon; Lee, Seok-Yong; Choi, Chang-Ik; Bae, Jung-Woo; Lee, Yun Jeong

ArticleIssue Date2023CitationArchives of Pharmacal Research, v.46, no.1, pp 59 - 64Publisher대한약학회
SCIESCOPUSKCI
Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes

Byeon, Ji-Yeong; Lee, Yun Jeong; Kim, Young-Hoon; Kim, Se-Hyung; Lee, Choong-Min; Bae, Jung-Woo; Jang, Choon-Gon; Lee, Seok-Yong; Choi, Chang-Ik

ArticleIssue Date2018CitationARCHIVES OF PHARMACAL RESEARCH, v.41, no.5, pp 564 - 570PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes

Cho, Chang-Keun; Kang, Pureum; Jang, Choon-Gon; Lee, Yun Jeong; Bae, Jung-Woo; Choi, Chang-Ik; Lee, Seok-Yong

ArticleIssue Date2025CitationArchives of Pharmacal Research, v.48, no.3, pp 224 - 233Publisher대한약학회
SCIESCOPUSKCI
Inhibition of salivary secretion by tolterodine transdermal patch

Byeon, Ji-Yeong; Kim, Young-Hoon; Kim, Se-Hyung; Lee, Choong-Min; Choi, Chang-Ik; Bae, Jung-Woo; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong

ArticleIssue Date2017CitationARCHIVES OF PHARMACAL RESEARCH, v.40, no.12, pp 1455 - 1463PublisherPHARMACEUTICAL SOC KOREA
SCIESCOPUSKCI
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes

Cho, Chang-Keun; Ko, Eunvin; Mo, Ju Yeon; Kang, Pureum; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Bae, Jung-Woo; Choi, Chang-Ik

ArticleIssue Date2024CitationArchives of Pharmacal Research, v.47, no.1, pp 82 - 94Publisher대한약학회
SCIESCOPUSKCI
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in diferent CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine

Cho, Chang-Keun; Kang, Pureum; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Bae, Jung-Woo; Choi, Chang-Ik

ArticleIssue Date2024CitationArchives of Pharmacal Research, v.47, no.5, pp 481 - 504Publisher대한약학회
SCIESCOPUSKCI
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypesopen access

Whang, Sang-Sup; Cho, Chang-Keun; Jung, Eui Hyun; Kang, Pureum; Park, Hye-Jung; Lee, Yun Jeong; Choi, Chang-Ik; Bae, Jung-Woo; Kim, Hyung Sik; Jang, Choon-Gon, et al.

ArticleIssue Date2022CitationArchives of Pharmacal Research, v.45, no.8, pp 584 - 595Publisher대한약학회
SCIESCOPUSKCI
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19

Park, Hye-Jung; Lee, Sang-Ho; Kang, Pureum; Cho, Chang-Keun; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Bae, Jung-Woo; Choi, Chang-Ik

ArticleIssue Date2025CitationArchives of Pharmacal Research, v.48, no.3, pp 234 - 250Publisher대한약학회
SCIESCOPUSKCI
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphismopen access

Cho, Chang-Keun; Kang, Pureum; Park, Hye-Jung; Ko, Eunvin; Mu, Chou Yen; Lee, Yun Jeong; Choi, Chang-Ik; Kim, Hyung Sik; Jang, Choon-Gon; Bae, Jung-Woo, et al.

ArticleIssue Date2022CitationArchives of Pharmacal Research, v.45, no.5, pp 352 - 366Publisher대한약학회
SCIESCOPUSKCI
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism

Cho, Chang-Keun; Mo, Ju Yeon; Ko, Eunvin; Kang, Pureum; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Bae, Jung-Woo; Choi, Chang-Ik

ArticleIssue Date2024CitationArchives of Pharmacal Research, v.47, no.2, pp 95 - 110Publisher대한약학회
SCIESCOPUSKCI
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypesopen access

Cho, Chang-Keun; Kang, Pureum; Jang, Choon-Gon; Lee, Seok-Yong; Lee, Yun Jeong; Choi, Chang-Ik

ArticleIssue Date2023CitationArchives of Pharmacal Research, v.46, no.11-12, pp 939 - 953Publisher대한약학회
1 2
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어